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ABSTRACT 
The fluorescent dihydropyrimido[1,2-a]quinoline chromophore of the pyoverdin siderophores has been synthesized 
by a biomimetic oxidative cyclisation using an iodine(III) reagent, followed by elimination and dehydrogenation.  
The pyoverdins are siderophores secreted by fluorescent 
Pseudomonas sp. including the pathogenic P. aeruginosa 
under conditions of iron starvation.1  Structurally they 
comprise a species-specific peptide of 6-19 residues 
containing D-amino acids and hydroxamates, and a 
characteristic 2,3-dihydro-1H-pyrimido[1,2-a]quinoline 
chromophore, as exemplified by pyoverdin Pf CCM2798 1 
from P. fluorescens (Figure 1).2  This example also 
illustrates the occurrence of the tetrahydropyrimidine 
amino acid unit in some pyoverdins.  Our interest in cyclic 
amidine amino acids as dipeptide mimics3 led us to prepare 
some tetrahydropyrimidine pseudodipeptides 2 related to 
pyoverdins (Figure 2).4  The chromophore is believed to be 
derived biogenetically by oxidative cyclisation of 
tetrahydropyrimidine amino acid residue 3, a proposal 
supported by incorporation studies with tyrosine and 2,4-
diaminobutyric acid,5 and by the co-occurrence of other 
related metabolites such as ferribactins,6 which lack the 
chromophore but contain the tyrosine-based 
tetrahydropyrimidine 3, isopyoverdins 47 and the 
corresponding 5,6-dihydro metabolites 5 and 6 (Figure 3).8 
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Figure 1. Structure of pyoverdin Pf CCM2798.  In subsequent 
structures substituents on the chromophore are represented as R 
groups. 
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Figure 2. Tetrahydropyrimidine pseudodipeptides  
 
 
N
H
N
R1HN
OH
N
N
R1HN
OH
3 4
CONHR2
N CONHR2
N
R1HN
OH
N
N
R1HN
OH
5 6
CONHR2
CONHR2
5
6
5
6
OH OH
OH
 
Figure 3. Co-metabolites biogenetically related to pyoverdins 
 
The recent demonstration of enzymic oxidation of the 
simple analogue 7 of tetrahydropyrimidine 3 to form a 
model for the dihydropyrimido[1,2-a]quinoline 
chromophore, albeit in very low yield,9,10 prompts us to 
report here our biomimetic chemical synthesis of a model 
for the pyoverdin chromophore, and of homologues in the 
cyclic amidine ring, using phenolic oxidation by 
hypervalent iodine.11 
The required substrates for oxidation were the phenolic 
cyclic amidines 7-9.  These were all prepared from 2-(4-
hydroxyphenyl)propanoic acid 10 by the sequence outlined 
in Scheme 1.  Treatment with benzyl bromide (K2CO3, 
acetone reflux) and subsequent ester hydrolysis (NaOH, 
MeOH aq) afforded the benzyl ether (98%) which was 
converted into amide 11 via the acid chloride (oxalyl 
chloride, THF, DMF cat; 96%) and ammonolysis (NH3 aq, 
d 0.88, THF; 76%).  After less reliable attempts at O-
alkylation with Meerwein’s salt, our preferred protocol for 
carboxamide activation was treatment with methyl 
trifluororomethanesulfonate (CH2Cl2, reflux) to afford the 
imidate salt 12 (we have also successfully employed S-
alkylation of piperidine thioamides to achieve this carboxyl 
activation4).  The crude imidate was treated directly with 
the appropriate diamine (EtOH, reflux) to form the required 
cyclic amidine.  Thus 1,3-diaminopropane led to the 
tetrahydropyrimidine 13 (n = 1) (83%)12 as its 
 
Scheme 1. Synthesis of cyclic amidine oxidation substrates 
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trifluoromethanesulfonate salt which was debenzylated by 
hydrogenolysis (Pd-C, 1 atm H2, EtOH) to afford oxidation 
substrate 7 (99%).  Likewise, reaction of 12 with 1,2-
diaminoethane or 1,4-diaminobutane, and subsequent 
hydrogenolysis, led to the corresponding imidazoline 8 (75 
and 99%)12 and 1,3-diazepine 9 (24 and 97%), respectively, 
again as the trifluoromethanesulfonate salts. 
Oxidative cyclisation of tetrahydropyrimidine 7 to the 
pyoverdin chromophore ring system requires closure via a 
nitrogen atom.  Our own studies and the work of others 
have clearly demonstrated that primary amides such as 11 
or the corresponding piperidine amides cyclise via the 
carbonyl oxygen atom on iodine(III) oxidation.13  Ring 
closure via nitrogen has been demonstrated for acyl 
hydrazides,14 sulfonamides,15 or cyclic imidates (oxazines, 
dihydrooxazoles) although in the latter case the imidate 
then undergoes cleavage.16  Since our initial attempts at 
direct oxidative cyclisation of the cyclic amidines 7-9 were 
unpromising, we elected to oxidize in the presence of 
nucleophilic alcohol solvents.17  Thus treatment of 
tetrahydropyrimidine 7 with 
bis(trifluoroacetoxy)iodobenzene (BTIB) in MeOH (20 ºC, 
5 min) afforded a dienone intermediate 14a (Table 1) that 
could not be fully characterised but when chromatographed 
on basic alumina afforded tetrahydropyrimidoquinolinone 
trifluoromethanesulfonate 15a (46%) as product of the 
desired oxidative cyclisation through a nitrogen atom.18  It 
is apparent that the intramolecular conjugate addition is 
alumina-mediated; indeed, stirring the dienone in solution 
with alumina also led to cyclisation, but chromatographic 
conversion was the more efficient protocol.  When the 
BTIB oxidation and alumina treatment sequence was 
repeated with EtOH as oxidation solvent, the corresponding 
tricyclic salt 15b was formed (34%) via dienone 14b.  
Likewise, 2-propanol, tert-butanol and benzyl alcohol 
 
 
Table 1. Oxidative cyclisation of pyrimidine 7 
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Entry R1 (±)-Dienone salt 
14a 
(±)-Pyrimidoquinolinone 
salt 15 (Yield %) 
1 OMe 14a 15a (46%) 
2 OEt 14b 15b (34%) 
3 OCHMe2 14c – 
4 OCMe3 14d – 
5 OCH2Ph 14e – 
6 NHCOMe 14f 15f (41%) 
7 OH 14g 15g (4%) 
aDienones 14 were not fully characterized. 
 
afforded dienones 14c-e that were not completely 
characterized.  From an oxidation in moist acetonitrile, 
the cyclisation product 15f was isolated (41%) via 
acetamide adduct 14f, and the hydroxyl adduct 15g was 
observed in low yield (approx. 4%) from a reaction in 
water, via 14g.  The structures of the methoxy-derivative 
15a and ethoxy-derivative 15b were confirmed by X-ray 
crystallographic analysis which also revealed cis-6,6-ring 
fusion in the crystalline material.19, 20 
Aromatisation of the carbocyclic ring by elimination of 
alcohol from 15a,b under acidic conditions was more 
difficult than originally anticipated, presumably because 
the quinolinones were already protonated at the amidine 
function, hindering alkoxy-group protonation. 
 
Scheme 2. Completion of the tetrahydropyrimidoquinolines  
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Treatment of 15a with trifluoromethanesulfonic acid 
afforded a mixture of the methoxy- and hydroxy-
tetrahydropyrimidoquinoline salts 16a and 16b.  We 
propose that O-alkylation arises by formation of the 
methylating agent methyl trifluoromethanesulfonate from 
the eliminated methanol in the reaction medium.  In 
support of this, addition of MeOH to the acidic reaction 
medium afforded methyl ether 16a as major product 
(57%) (Scheme 2).  In contrast elimination from ethoxy 
compound 15b afforded solely the phenolic 
dihydropyrimidinoquinoline 16b (38%), as presumably 
any ethyl trifluoromethanesulfonate formed is either less 
effective as an alkylating agent, or undergoes elimination.  
The structure of methyl ether 16a was confirmed by an X-
ray crystal structure.19  Completion of the pyoverdin 
chromophore model was achieved by dehydrogenation of 
16a using DDQ (1,4-dioxane, reflux) to afford tricyclic 
salt 17a (38%), purified by reverse-phase HPLC; the 
structure of 17a was also confirmed by a crystal structure 
determination.  Dehydrogenation of 16b could also be 
achieved in low yield (10%) to give a highly polar 
product 17b that was not fully characterized.  These 
dehydrogenations could also be achieved on silica by 
microwave irradiation, but gave less pure products. 
The oxidative cyclisation sequence was also performed 
on the imidazoline 8 and 1,3-diazepine 9 (Scheme 3).  
Thus BTIB oxidation using MeOH or EtOH as solvent, 
and subsequent alumina chromatography, afforded 
reduced imidazoquinolinone trifluoromethanesufonates  
 
Scheme 3. Oxidative cyclisations of imidazoline 8, diazepine 9 
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18a and 18b from imidazoline 8 (39% and 16%, 
respectively).  Diazepine 9 similarly afforded the reduced 
alkoxyazepinoquinolinone salts 19a and 19b (44% and 
29%, respectively).  Intermediates 18 have not been taken 
further, but treatment of both 19a and 19b in 
trifluoromethanesulfonic acid-MeOH gave the 
methoxyhexahydroazepinoquinoline salt 20 (66% and 
50%, respectively).  DDQ dehydrogenation of 20 as 
previously led to the homologue 21 of the pyoverdin 
chromophore model (35%). 
The dihydropyrimidoquinoline 17a showed strong 
fluorescence,21 as do the natural pyoverdins; the seven-
ring analogue 21 showed a much weaker fluorescence 
(approx. 25% of that of 17a). The UV spectra of 
chromophores 17 and 21 compared acceptably with those 
of the natural pyoverdins,22 recognising that they have an 
incomplete substituent set.  
We have thus chemically generated models for the 
dihydropyrimido[1,2-a]quinoline chromophore of the 
pyoverdin siderophores via a biomimetic route involving 
oxidative cyclisation.  Efforts continue towards synthesis 
of the pyoverdins. 
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